Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2279 (LINC02279)

Target
LINC02279
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2279 (LINC02279) is a member of the long intergenic non-coding RNA (lincRNA) family, transcribed from a genomic region not overlapping protein-coding loci[1][5]. Like other lincRNAs, it is thought to function primarily in the regulation of gene expression and possibly chromatin architecture; however, its specific function, disease relevance, and molecular interactions remain unknown due to a lack of published research characterizing this particular transcript in detail. LINC02279 is referenced in genomic databases as a distinct RNA gene, but as of this date, there is no experimental or clinical literature highlighting therapeutic, diagnostic, or prognostic roles for this molecule[1][5][3].

Other names
None known beyond LINC02279; alternative names not documented in major databases
02

Mechanism of action

None documented

03

Biological functions

Gene expression regulation (inferred by analogy to the general class of lincRNAs, which modulate nuclear architecture, chromatin remodeling, transcription, and mRNA stability)
04

Disease associations

Other (no direct evidence or publications specifically associating LINC02279 itself with particular diseases or pathological roles as of current data)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2279 (LINC02279).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2279 (LINC02279).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call